Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical recombinant human epidermal growth factor gel plus fractional radiofrequency microneedle for mild to moderate atrophic acne scars
TCTR20201201003Phase 3Recruiting
- Start
- Nov 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of nepidermin in acne scar, sponsored by none. Started Nov 2020; status: recruiting.
02
Drugs
nepidermin
03
Conditions
acne scar
Beyond the preview
Go deeper on TCTR20201201003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20201201003.